{
  "DOI": "10.1186/s40246-024-00592-x",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-024-00592-x",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eProtein Phosphatase Enzymes (PPE) and protein kinases simultaneously control phosphorylation mechanisms that tightly regulate intracellular signalling pathways and stimulate cellular responses. In human malignancies, PPE and protein kinases are frequently mutated resulting in uncontrolled kinase activity and PPE suppression, leading to cell proliferation, migration and resistance to anti-cancer therapies. Cancer associated DNA hypermethylation at PPE promoters gives rise to transcriptional silencing (epimutations) and is a hallmark of cancer. Despite recent advances in sequencing technologies, data availability and computational capabilities, only a fraction of PPE have been reported as transcriptionally inactive as a consequence of epimutations.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eIn this study, we examined promoter-associated DNA methylation profiles in Protein Phosphatase Enzymes and their Interacting Proteins (PPEIP) in a cohort of 705 cancer patients in five tissues (Large intestine, Oesophagus, Lung, Pancreas and Stomach) in three cell models (primary tumours, cancer cell lines and 3D embedded cancer cell cultures). As a subset of PPEIP are known tumour suppressor genes, we analysed the impact of PPEIP promoter hypermethylation marks on gene expression, cellular networks and in a clinical setting.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eHere, we report epimutations in PPEIP are a frequent occurrence in the cancer genome and manifest independent of transcriptional activity. We observed that different tumours have varying susceptibility to epimutations and identify specific cellular signalling networks that are primarily affected by epimutations. Additionally, RNA-seq analysis showed the negative impact of epimutations on most (not all) Protein Tyrosine Phosphatase transcription. Finally, we detected novel clinical biomarkers that inform on patient mortality and anti-cancer treatment sensitivity.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eWe propose that DNA hypermethylation marks at PPEIP frequently contribute to the pathogenesis of malignancies and within the precision medicine space, hold promise as biomarkers to inform on clinical features such as patient survival and therapeutic response.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "592"
  ],
  "article-number": "24",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "3 November 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "27 February 2024"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "12 March 2024"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Wiltshire",
      "given": "Edward",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "de Moura",
      "given": "Manuel Castro",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Piñeyro",
      "given": "David",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Joshi",
      "given": "Ricky S.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2024,
        3,
        12
      ]
    ],
    "date-time": "2024-03-12T19:02:32Z",
    "timestamp": 1710270152000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        3,
        12
      ]
    ],
    "date-time": "2024-03-12T19:04:26Z",
    "timestamp": 1710270266000
  },
  "funder": [
    {
      "DOI": "10.13039/501100014139",
      "doi-asserted-by": "publisher",
      "name": "Centro de Investigación Biomédica en Red de Cáncer"
    },
    {
      "DOI": "10.13039/100015884",
      "doi-asserted-by": "publisher",
      "name": "Fundación Olga Torres"
    },
    {
      "DOI": "10.13039/501100000738",
      "doi-asserted-by": "publisher",
      "name": "University of Leicester"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        19
      ]
    ],
    "date-time": "2024-03-19T00:33:28Z",
    "timestamp": 1710808408156
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2024,
        3,
        12
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2024,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            3,
            12
          ]
        ],
        "date-time": "2024-03-12T00:00:00Z",
        "timestamp": 1710201600000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            3,
            12
          ]
        ],
        "date-time": "2024-03-12T00:00:00Z",
        "timestamp": 1710201600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-024-00592-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-024-00592-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-024-00592-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2024,
        3,
        12
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2024,
        3,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1146/annurev.bi.58.070189.002321",
      "author": "P Cohen",
      "doi-asserted-by": "publisher",
      "first-page": "453",
      "journal-title": "Annu Rev Biochem",
      "key": "592_CR1",
      "unstructured": "Cohen P. The structure and regulation of protein phosphatases. Annu Rev Biochem. 1989;58:453–508.",
      "volume": "58",
      "year": "1989"
    },
    {
      "DOI": "10.1038/onc.2013.80",
      "author": "J Stebbing",
      "doi-asserted-by": "publisher",
      "first-page": "939",
      "journal-title": "Oncogene",
      "key": "592_CR2",
      "unstructured": "Stebbing J, Lit LC, Zhang H, Darrington RS, Melaiu O, Rudraraju B, et al. The regulatory roles of phosphatases in cancer. Oncogene. 2014;33:939–53.",
      "volume": "33",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nrm2039",
      "author": "NK Tonks",
      "doi-asserted-by": "publisher",
      "first-page": "833",
      "journal-title": "Nat Rev Mol Cell Biol",
      "key": "592_CR3",
      "unstructured": "Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol. 2006;7:833–46.",
      "volume": "7",
      "year": "2006"
    },
    {
      "DOI": "10.1146/annurev.biophys.27.1.133",
      "author": "D Barford",
      "doi-asserted-by": "publisher",
      "first-page": "133",
      "journal-title": "Annu Rev Biophys Biomol Struct",
      "key": "592_CR4",
      "unstructured": "Barford D, Das AK, Egloff M-P, THE STRUCTURE AND, MECHANISM OF PROTEIN PHOSPHATASES. Insights into Catalysis and Regulation. Annu Rev Biophys Biomol Struct. 1998;27:133–64.",
      "volume": "27",
      "year": "1998"
    },
    {
      "DOI": "10.1126/scisignal.2003203",
      "doi-asserted-by": "crossref",
      "key": "592_CR5",
      "unstructured": "Li X, Wilmanns M, Thornton J, Köhn M. Elucidating human phosphatase-substrate networks. Sci Signal. 2013;6."
    },
    {
      "DOI": "10.4061/2011/329098",
      "author": "A Bononi",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Enzyme Res",
      "key": "592_CR6",
      "unstructured": "Bononi A, Agnoletto C, De Marchi E, Marchi S, Patergnani S, Bonora M, et al. Protein kinases and phosphatases in the control of cell fate. Enzyme Res. 2011;2011:1–26.",
      "volume": "2011",
      "year": "2011"
    },
    {
      "DOI": "10.3389/fcell.2021.690306",
      "doi-asserted-by": "crossref",
      "key": "592_CR7",
      "unstructured": "Turdo A, D’Accardo C, Glaviano A, Porcelli G, Colarossi C, Colarossi L et al. Targeting phosphatases and kinases: how to Checkmate Cancer. Front Cell Dev Biol. 2021;9."
    },
    {
      "DOI": "10.1007/978-3-319-32805-8_10",
      "doi-asserted-by": "crossref",
      "key": "592_CR8",
      "unstructured": "Fontanillo M, Köhn M, Phosphatases. Their Roles in Cancer and Their Chemical Modulators. 2016. p. 209–40."
    },
    {
      "DOI": "10.1126/science.275.5308.1943",
      "author": "J Li",
      "doi-asserted-by": "publisher",
      "first-page": "1943",
      "journal-title": "Science",
      "key": "592_CR9",
      "unstructured": "Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275:1943–7.",
      "volume": "275",
      "year": "1997"
    },
    {
      "DOI": "10.1038/sj.onc.1203389",
      "author": "GA Calin",
      "doi-asserted-by": "publisher",
      "first-page": "1191",
      "journal-title": "Oncogene",
      "key": "592_CR10",
      "unstructured": "Calin GA, Di Iasio MG, Caprini E, Vorechovsky I, Natali PG, Sozzi G, et al. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit a of the serine-threonine phosphatase 2A in human neoplasms. Oncogene. 2000;19:1191–5.",
      "volume": "19",
      "year": "2000"
    },
    {
      "DOI": "10.1155/2012/659649",
      "author": "Q Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Enzyme Res",
      "key": "592_CR11",
      "unstructured": "Zhang Q, Claret FX, Phosphatases. The New brakes for Cancer Development? Enzyme Res. 2012;2012:1–11.",
      "volume": "2012",
      "year": "2012"
    },
    {
      "DOI": "10.18632/aging.100296",
      "author": "LS Steelman",
      "doi-asserted-by": "publisher",
      "first-page": "192",
      "journal-title": "Aging",
      "key": "592_CR12",
      "unstructured": "Steelman LS, Chappell WH, Abrams SL, Kempf CR, Long J, Laidler P, et al. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging. 2011;3:192.",
      "volume": "3",
      "year": "2011"
    },
    {
      "DOI": "10.1126/science.1096096",
      "author": "Z Wang",
      "doi-asserted-by": "publisher",
      "first-page": "1164",
      "journal-title": "Sci (80-)",
      "key": "592_CR13",
      "unstructured": "Wang Z. Mutational analysis of the Tyrosine Phosphatome in Colorectal cancers. Sci (80-). 2004;304:1164–6.",
      "volume": "304",
      "year": "2004"
    },
    {
      "DOI": "10.3892/etm.2011.231",
      "author": "K FUNATO",
      "doi-asserted-by": "publisher",
      "first-page": "457",
      "journal-title": "Exp Ther Med",
      "key": "592_CR14",
      "unstructured": "FUNATO K, YAMAZUMI Y, ODA T. Tyrosine phosphatase PTPRD suppresses colon cancer cell migration in coordination with CD44. Exp Ther Med. 2011;2:457–63.",
      "volume": "2",
      "year": "2011"
    },
    {
      "DOI": "10.1073/pnas.0900571106",
      "author": "S Veeriah",
      "doi-asserted-by": "publisher",
      "first-page": "9435",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "592_CR15",
      "unstructured": "Veeriah S, Brennan C, Meng S, Singh B, Fagin JA, Solit DB, et al. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc Natl Acad Sci U S A. 2009;106:9435–40.",
      "volume": "106",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.molcel.2016.12.004",
      "author": "Z Yao",
      "doi-asserted-by": "publisher",
      "first-page": "347",
      "journal-title": "Mol Cell",
      "key": "592_CR16",
      "unstructured": "Yao Z, Darowski K, St-Denis N, Wong V, Offensperger F, Villedieu A, et al. A Global Analysis of the receptor tyrosine kinase-protein phosphatase interactome. Mol Cell. 2017;65:347–60.",
      "volume": "65",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ajpath.2011.11.038",
      "author": "M Scrima",
      "doi-asserted-by": "publisher",
      "first-page": "1202",
      "journal-title": "Am J Pathol",
      "key": "592_CR17",
      "unstructured": "Scrima M, De Marco C, De Vita F, Fabiani F, Franco R, Pirozzi G, et al. The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non–small cell Lung Cancer. Am J Pathol. 2012;180:1202–14.",
      "volume": "180",
      "year": "2012"
    },
    {
      "DOI": "10.1111/j.1742-4658.2012.08716.x",
      "author": "CJ Caunt",
      "doi-asserted-by": "publisher",
      "first-page": "489",
      "journal-title": "FEBS J",
      "key": "592_CR18",
      "unstructured": "Caunt CJ, Keyse SM. Dual-specificity MAP kinase phosphatases (MKPs). FEBS J. 2013;280:489–504.",
      "volume": "280",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.bbcan.2014.04.006",
      "author": "S Muniyan",
      "doi-asserted-by": "publisher",
      "first-page": "88",
      "journal-title": "Biochim Biophys Acta - Rev Cancer",
      "key": "592_CR19",
      "unstructured": "Muniyan S, Ingersoll MA, Batra SK, Lin M-F. Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor. Biochim Biophys Acta - Rev Cancer. 2014;1846:88–98.",
      "volume": "1846",
      "year": "2014"
    },
    {
      "DOI": "10.1186/s12863-015-0238-4",
      "author": "C Hedberg Oldfors",
      "doi-asserted-by": "publisher",
      "first-page": "80",
      "journal-title": "BMC Genet",
      "key": "592_CR20",
      "unstructured": "Hedberg Oldfors C, Dios DG, Linder A, Visuttijai K, Samuelson E, Karlsson S, et al. Analysis of an independent tumor suppressor locus telomeric to Tp53 suggested Inpp5k and Myo1c as novel tumor suppressor gene candidates in this region. BMC Genet. 2015;16:80.",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMra072067",
      "author": "M Esteller",
      "doi-asserted-by": "publisher",
      "first-page": "1148",
      "journal-title": "N Engl J Med",
      "key": "592_CR21",
      "unstructured": "Esteller M. Epigenetics in Cancer. N Engl J Med. 2008;358:1148–59.",
      "volume": "358",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.semcancer.2020.12.011",
      "author": "V Ortiz-Barahona",
      "doi-asserted-by": "publisher",
      "journal-title": "Semin Cancer Biol",
      "key": "592_CR22",
      "unstructured": "Ortiz-Barahona V, Joshi RS, Esteller M. Use of DNA methylation profiling in translational oncology. Semin Cancer Biol. 2020. https://doi.org/10.1016/j.semcancer.2020.12.011.",
      "year": "2020"
    },
    {
      "DOI": "10.2147/OTT.S111684",
      "author": "S Luo",
      "doi-asserted-by": "publisher",
      "first-page": "5643",
      "journal-title": "Onco Targets Ther",
      "key": "592_CR23",
      "unstructured": "Luo S, Chen J, Mo X. The association of PTEN hypermethylation and breast cancer: a meta-analysis. Onco Targets Ther. 2016;9:5643–50.",
      "volume": "9",
      "year": "2016"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-05-2072",
      "author": "DK Vanaja",
      "doi-asserted-by": "publisher",
      "first-page": "1128",
      "journal-title": "Clin Cancer Res",
      "key": "592_CR24",
      "unstructured": "Vanaja DK, Ballman KV, Morlan BW, Cheville JC, Neumann RM, Lieber MM, et al. PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer. Clin Cancer Res. 2006;12:1128–36.",
      "volume": "12",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.leu.2404193",
      "author": "J Ying",
      "doi-asserted-by": "publisher",
      "first-page": "1173",
      "journal-title": "Leukemia",
      "key": "592_CR25",
      "unstructured": "Ying J, Li H, Cui Y, Wong AHY, Langford C, Tao Q. Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter. Leukemia. 2006;20:1173–5.",
      "volume": "20",
      "year": "2006"
    },
    {
      "DOI": "10.3892/ol.2017.6506",
      "author": "D Li",
      "doi-asserted-by": "publisher",
      "first-page": "2643",
      "journal-title": "Oncol Lett",
      "key": "592_CR26",
      "unstructured": "Li D, Guo J, Wang S, Zhu L, Shen Z. Identification of novel methylated targets in colorectal cancer by microarray analysis and construction of co–expression network. Oncol Lett. 2017;14:2643–8.",
      "volume": "14",
      "year": "2017"
    },
    {
      "DOI": "10.1002/cam4.273",
      "author": "K Takane",
      "doi-asserted-by": "publisher",
      "first-page": "1235",
      "journal-title": "Cancer Med",
      "key": "592_CR27",
      "unstructured": "Takane K, Midorikawa Y, Yagi K, Sakai A, Aburatani H, Takayama T, et al. Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients. Cancer Med. 2014;3:1235–45.",
      "volume": "3",
      "year": "2014"
    },
    {
      "DOI": "10.1530/EC-19-0279",
      "author": "E Barazeghi",
      "doi-asserted-by": "publisher",
      "first-page": "1126",
      "journal-title": "Endocr Connect",
      "key": "592_CR28",
      "unstructured": "Barazeghi E, Hellman P, Westin G, Stålberg P. PTPRM, a candidate tumor suppressor gene in small intestinal neuroendocrine tumors. Endocr Connect. 2019;8:1126–35.",
      "volume": "8",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41598-018-20176-9",
      "author": "L Tögel",
      "doi-asserted-by": "publisher",
      "first-page": "1767",
      "journal-title": "Sci Rep",
      "key": "592_CR29",
      "unstructured": "Tögel L, Nightingale R, Wu R, Chüeh AC, Al-Obaidi S, Luk I, et al. DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis. Sci Rep. 2018;8:1767.",
      "volume": "8",
      "year": "2018"
    },
    {
      "DOI": "10.1084/jem.20141957",
      "author": "CA Schmid",
      "doi-asserted-by": "publisher",
      "first-page": "775",
      "journal-title": "J Exp Med",
      "key": "592_CR30",
      "unstructured": "Schmid CA, Robinson MD, Scheifinger NA, Müller S, Cogliatti S, Tzankov A, et al. DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma. J Exp Med. 2015;212:775–92.",
      "volume": "212",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.cell.2016.06.017",
      "author": "F Iorio",
      "doi-asserted-by": "publisher",
      "first-page": "740",
      "journal-title": "Cell",
      "key": "592_CR31",
      "unstructured": "Iorio F, Knijnenburg TA, Vis DJ, Bignell GR, Menden MP, Schubert M, et al. A Landscape of Pharmacogenomic interactions in Cancer. Cell. 2016;166:740–54.",
      "volume": "166",
      "year": "2016"
    },
    {
      "key": "592_CR32",
      "unstructured": "Team RC, R Core Team. (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/."
    },
    {
      "DOI": "10.1093/bioinformatics/btu049",
      "author": "MJ Aryee",
      "doi-asserted-by": "publisher",
      "first-page": "1363",
      "journal-title": "Bioinformatics",
      "key": "592_CR33",
      "unstructured": "Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30:1363–9.",
      "volume": "30",
      "year": "2014"
    },
    {
      "DOI": "10.1101/065490",
      "doi-asserted-by": "crossref",
      "key": "592_CR34",
      "unstructured": "Fortin J-P, Triche TJ, Hansen KD. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics. 2016. btw691."
    },
    {
      "DOI": "10.1080/15592294.2020.1762398",
      "author": "R Joshi",
      "doi-asserted-by": "publisher",
      "first-page": "1167",
      "journal-title": "Epigenetics",
      "key": "592_CR35",
      "unstructured": "Joshi R, Castro De Moura M, Piñeyro D, Alvarez-Errico D, Arribas C, Esteller M. The DNA methylation landscape of human cancer organoids available at the American type culture collection. Epigenetics. 2020;15:1167–77.",
      "volume": "15",
      "year": "2020"
    },
    {
      "DOI": "10.1093/bioinformatics/btl117",
      "author": "R Suzuki",
      "doi-asserted-by": "publisher",
      "first-page": "1540",
      "journal-title": "Bioinformatics",
      "key": "592_CR36",
      "unstructured": "Suzuki R, Shimodaira H. Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics. 2006;22:1540–2.",
      "volume": "22",
      "year": "2006"
    },
    {
      "DOI": "10.18637/jss.v053.i09",
      "doi-asserted-by": "crossref",
      "key": "592_CR37",
      "unstructured": "Müllner D. Fastcluster: fast hierarchical, agglomerative clustering routines for R and Python. J Stat Softw. 2013;53."
    },
    {
      "author": "LJP van der Maaten",
      "first-page": "2579",
      "journal-title": "J Mach Learn Res",
      "key": "592_CR38",
      "unstructured": "van der Maaten LJP, Hinton GE. Visualizing high-dimensional data using t-SNE. J Mach Learn Res. 2008;9:2579–605.",
      "volume": "9",
      "year": "2008"
    },
    {
      "author": "LVD M",
      "first-page": "3221",
      "journal-title": "J Mach Learn Res",
      "key": "592_CR39",
      "unstructured": "LVD M. Accelerating t-SNE using tree-based algorithms. J Mach Learn Res. 2014;15:3221–45.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1093/nar/gkv1507",
      "author": "A Colaprico",
      "doi-asserted-by": "publisher",
      "first-page": "e71",
      "journal-title": "Nucleic Acids Res",
      "key": "592_CR40",
      "unstructured": "Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44:e71–1.",
      "volume": "44",
      "year": "2016"
    },
    {
      "DOI": "10.12688/f1000research.8923.1",
      "author": "TC Silva",
      "doi-asserted-by": "publisher",
      "first-page": "1542",
      "journal-title": "F1000Research",
      "key": "592_CR41",
      "unstructured": "Silva TC, Colaprico A, Olsen C, D’Angelo F, Bontempi G, Ceccarelli M, et al. TCGA Workflow: analyze cancer genomics and epigenomics data using Bioconductor packages. F1000Research. 2016;5:1542.",
      "volume": "5",
      "year": "2016"
    },
    {
      "DOI": "10.1371/journal.pone.0132517",
      "author": "L Simo-Riudalbas",
      "doi-asserted-by": "publisher",
      "first-page": "e0132517",
      "journal-title": "PLoS ONE",
      "key": "592_CR42",
      "unstructured": "Simo-Riudalbas L, Diaz-Lagares A, Gatto S, Gagliardi M, Crujeiras AB, Matarazzo MR, et al. Genome-wide DNA methylation analysis identifies Novel hypomethylated non-pericentromeric genes with potential clinical implications in ICF Syndrome. PLoS ONE. 2015;10:e0132517.",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1172/jci.insight.125888",
      "doi-asserted-by": "crossref",
      "key": "592_CR43",
      "unstructured": "Llinàs-Arias P, Rosselló-Tortella M, López-Serra P, Pérez-Salvia M, Setién F, Marin S et al. Epigenetic loss of the endoplasmic reticulum–associated degradation inhibitor SVIP induces cancer cell metabolic reprogramming. JCI Insight. 2019;4."
    },
    {
      "DOI": "10.1073/pnas.2003358117",
      "author": "M Rosselló-Tortella",
      "doi-asserted-by": "publisher",
      "first-page": "20785",
      "journal-title": "Proc Natl Acad Sci",
      "key": "592_CR44",
      "unstructured": "Rosselló-Tortella M, Llinàs-Arias P, Sakaguchi Y, Miyauchi K, Davalos V, Setien F, et al. Epigenetic loss of the transfer RNA-modifying enzyme TYW2 induces ribosome frameshifts in colon cancer. Proc Natl Acad Sci. 2020;117:20785–93.",
      "volume": "117",
      "year": "2020"
    },
    {
      "DOI": "10.1093/nar/gkw377",
      "author": "MV Kuleshov",
      "doi-asserted-by": "publisher",
      "first-page": "W90",
      "journal-title": "Nucleic Acids Res",
      "key": "592_CR45",
      "unstructured": "Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90–7.",
      "volume": "44",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s13277-015-4489-5",
      "author": "P Ye",
      "doi-asserted-by": "publisher",
      "first-page": "6893",
      "journal-title": "Tumor Biol",
      "key": "592_CR46",
      "unstructured": "Ye P, Qu C-F, Hu X-L. Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma. Tumor Biol. 2016;37:6893–904.",
      "volume": "37",
      "year": "2016"
    },
    {
      "DOI": "10.1593/neo.07760",
      "author": "T Kawasaki",
      "doi-asserted-by": "publisher",
      "first-page": "1091",
      "journal-title": "Neoplasia",
      "key": "592_CR47",
      "unstructured": "Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS, et al. IGFBP3 promoter methylation in Colorectal Cancer: relationship with microsatellite instability, CpG Island Methylator phenotype, p53. Neoplasia. 2007;9:1091–8.",
      "volume": "9",
      "year": "2007"
    },
    {
      "DOI": "10.1186/1476-4598-8-120",
      "author": "P-L Torng",
      "doi-asserted-by": "publisher",
      "first-page": "120",
      "journal-title": "Mol Cancer",
      "key": "592_CR48",
      "unstructured": "Torng P-L, Lin C-W, Chan MW, Yang H-W, Huang S-C, Lin C-T. Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma. Mol Cancer. 2009;8:120.",
      "volume": "8",
      "year": "2009"
    },
    {
      "DOI": "10.1038/cddis.2013.140",
      "author": "H Akl",
      "doi-asserted-by": "publisher",
      "first-page": "e632",
      "journal-title": "Cell Death Dis",
      "key": "592_CR49",
      "unstructured": "Akl H, Monaco G, La Rovere R, Welkenhuyzen K, Kiviluoto S, Vervliet T, et al. IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2. Cell Death Dis. 2013;4:e632.",
      "volume": "4",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.tox.2009.05.006",
      "author": "J Kopacek",
      "doi-asserted-by": "publisher",
      "first-page": "73",
      "journal-title": "Toxicology",
      "key": "592_CR50",
      "unstructured": "Kopacek J, Ondrias K, Sedlakova B, Tomaskova J, Zahradnikova L, Sedlak J, et al. Type 2 IP(3) receptors are involved in uranyl acetate induced apoptosis in HEK 293 cells. Toxicology. 2009;262:73–9.",
      "volume": "262",
      "year": "2009"
    },
    {
      "DOI": "10.1038/cddis.2013.512",
      "author": "L Liu",
      "doi-asserted-by": "publisher",
      "first-page": "e988",
      "journal-title": "Cell Death Dis",
      "key": "592_CR51",
      "unstructured": "Liu L, Wen Q, Gong R, Gilles L, Stankiewicz MJ, Li W, et al. PSTPIP2 dysregulation contributes to aberrant terminal differentiation in GATA-1-deficient megakaryocytes by activating LYN. Cell Death Dis. 2014;5:e988–8.",
      "volume": "5",
      "year": "2014"
    },
    {
      "DOI": "10.1093/jjco/hyx182",
      "author": "H Wang",
      "doi-asserted-by": "publisher",
      "first-page": "175",
      "journal-title": "Jpn J Clin Oncol",
      "key": "592_CR52",
      "unstructured": "Wang H, Zhao S, Chen B, Fu C, Dang Y, Fang P, et al. Repression of the expression of PPP3CC by ZEB1 confers activation of NF-κB and contributes to invasion and growth in glioma cells. Jpn J Clin Oncol. 2018;48:175–83.",
      "volume": "48",
      "year": "2018"
    },
    {
      "author": "T Kohno",
      "first-page": "4170",
      "journal-title": "Cancer Res",
      "key": "592_CR53",
      "unstructured": "Kohno T, Takakura S, Yamada T, Okamoto A, Tanaka T, Yokota J. Alterations of the PPP1R3 gene in human cancer. Cancer Res. 1999;59:4170–4.",
      "volume": "59",
      "year": "1999"
    },
    {
      "DOI": "10.1038/nature08138",
      "author": "Y Okabe",
      "doi-asserted-by": "publisher",
      "first-page": "520",
      "journal-title": "Nature",
      "key": "592_CR54",
      "unstructured": "Okabe Y, Sano T, Nagata S. Regulation of the innate immune response by threonine-phosphatase of eyes absent. Nature. 2009;460:520–4.",
      "volume": "460",
      "year": "2009"
    },
    {
      "DOI": "10.1002/mc.22247",
      "author": "S-J Kim",
      "doi-asserted-by": "publisher",
      "first-page": "1748",
      "journal-title": "Mol Carcinog",
      "key": "592_CR55",
      "unstructured": "Kim S-J, Tae CH, Hong SN, Min B-H, Chang DK, Rhee P-L, et al. EYA4 acts as a new tumor suppressor gene in Colorectal Cancer. Mol Carcinog. 2015;54:1748–57.",
      "volume": "54",
      "year": "2015"
    },
    {
      "DOI": "10.1111/cas.13615",
      "author": "M Luo",
      "doi-asserted-by": "publisher",
      "first-page": "1811",
      "journal-title": "Cancer Sci",
      "key": "592_CR56",
      "unstructured": "Luo M, Li Y, Shi X, Yang W, Zhou F, Sun N, et al. Aberrant methylation of EYA4 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Cancer Sci. 2018;109:1811–24.",
      "volume": "109",
      "year": "2018"
    },
    {
      "DOI": "10.1038/onc.2013.396",
      "author": "IM Wilson",
      "doi-asserted-by": "publisher",
      "first-page": "4464",
      "journal-title": "Oncogene",
      "key": "592_CR57",
      "unstructured": "Wilson IM, Vucic EA, Enfield KSS, Thu KL, Zhang YA, Chari R, et al. EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk. Oncogene. 2014;33:4464–73.",
      "volume": "33",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.canlet.2016.06.021",
      "author": "S-J Mo",
      "doi-asserted-by": "publisher",
      "first-page": "403",
      "journal-title": "Cancer Lett",
      "key": "592_CR58",
      "unstructured": "Mo S-J, Liu X, Hao X-Y, Chen W, Zhang K-S, Cai J-P, et al. EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway. Cancer Lett. 2016;380:403–12.",
      "volume": "380",
      "year": "2016"
    },
    {
      "DOI": "10.1038/onc.2009.360",
      "author": "SJ Miller",
      "doi-asserted-by": "publisher",
      "first-page": "368",
      "journal-title": "Oncogene",
      "key": "592_CR59",
      "unstructured": "Miller SJ, Lan ZD, Hardiman A, Wu J, Kordich JJ, Patmore DM, et al. Inhibition of eyes absent homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis. Oncogene. 2010;29:368–79.",
      "volume": "29",
      "year": "2010"
    },
    {
      "DOI": "10.1158/2159-8290.CD-14-0765",
      "author": "A Vaishnavi",
      "doi-asserted-by": "publisher",
      "first-page": "25",
      "journal-title": "Cancer Discov",
      "key": "592_CR60",
      "unstructured": "Vaishnavi A, Le AT, Doebele RC. TRKing down an old oncogene in a new era of targeted therapy. Cancer Discov. 2015;5:25–34.",
      "volume": "5",
      "year": "2015"
    },
    {
      "DOI": "10.1073/pnas.1212333110",
      "author": "A-L Genevois",
      "doi-asserted-by": "publisher",
      "first-page": "3017",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "592_CR61",
      "unstructured": "Genevois A-L, Ichim G, Coissieux M-M, Lambert M-P, Lavial F, Goldschneider D, et al. Dependence receptor TrkC is a putative colon cancer tumor suppressor. Proc Natl Acad Sci U S A. 2013;110:3017–22.",
      "volume": "110",
      "year": "2013"
    },
    {
      "DOI": "10.1089/152791601750294344",
      "author": "D Nishimura",
      "doi-asserted-by": "publisher",
      "first-page": "117",
      "journal-title": "Biotech Softw Internet Rep",
      "key": "592_CR62",
      "unstructured": "Nishimura D, BioCarta. Biotech Softw Internet Rep. 2001;2:117–20.",
      "volume": "2",
      "year": "2001"
    },
    {
      "DOI": "10.1093/nar/gkv1070",
      "author": "M Kanehisa",
      "doi-asserted-by": "publisher",
      "first-page": "D457",
      "journal-title": "Nucleic Acids Res",
      "key": "592_CR63",
      "unstructured": "Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44:D457–62.",
      "volume": "44",
      "year": "2016"
    },
    {
      "DOI": "10.1371/journal.pbio.0060184",
      "author": "AR Pico",
      "doi-asserted-by": "publisher",
      "first-page": "e184",
      "journal-title": "PLoS Biol",
      "key": "592_CR64",
      "unstructured": "Pico AR, Kelder T, van Iersel MP, Hanspers K, Conklin BR, Evelo C. WikiPathways: pathway editing for the people. PLoS Biol. 2008;6:e184.",
      "volume": "6",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.ctrv.2003.07.007",
      "author": "JÁF Vara",
      "doi-asserted-by": "publisher",
      "first-page": "193",
      "journal-title": "Cancer Treat Rev",
      "key": "592_CR65",
      "unstructured": "Vara JÁF, Casado E, de Castro J, Cejas P, Belda-Iniesta C, González-Barón M. PI3K/Akt signalling pathway and cancer. Cancer Treat Rev. 2004;30:193–204.",
      "volume": "30",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.onc.1210421",
      "author": "AS Dhillon",
      "doi-asserted-by": "publisher",
      "first-page": "3279",
      "journal-title": "Oncogene",
      "key": "592_CR66",
      "unstructured": "Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene. 2007;26:3279–90.",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1038/s41416-019-0663-7",
      "author": "C Seth Nanda",
      "doi-asserted-by": "publisher",
      "first-page": "136",
      "journal-title": "Br J Cancer",
      "key": "592_CR67",
      "unstructured": "Seth Nanda C, Venkateswaran SV, Patani N, Yuneva M. Defining a metabolic landscape of tumours: genome meets metabolism. Br J Cancer. 2020;122:136–49.",
      "volume": "122",
      "year": "2020"
    },
    {
      "DOI": "10.1038/nrd1902",
      "author": "BT Hennessy",
      "doi-asserted-by": "publisher",
      "first-page": "988",
      "journal-title": "Nat Rev Drug Discov",
      "key": "592_CR68",
      "unstructured": "Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for Cancer Drug Discovery. Nat Rev Drug Discov. 2005;4:988–1004.",
      "volume": "4",
      "year": "2005"
    },
    {
      "DOI": "10.3390/ijms21031102",
      "doi-asserted-by": "crossref",
      "key": "592_CR69",
      "unstructured": "Lee S, Rauch J, Kolch W. Targeting MAPK signaling in Cancer: mechanisms of Drug Resistance and Sensitivity. Int J Mol Sci. 2020;21."
    },
    {
      "DOI": "10.1089/ars.2019.7947",
      "author": "NYL Ngoi",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "journal-title": "Antioxid Redox Signal",
      "key": "592_CR70",
      "unstructured": "Ngoi NYL, Eu JQ, Hirpara J, Wang L, Lim JSJ, Lee S-C, et al. Targeting cell metabolism as Cancer Therapy. Antioxid Redox Signal. 2020;32:285–308.",
      "volume": "32",
      "year": "2020"
    },
    {
      "DOI": "10.1038/onc.2014.257",
      "author": "D Zhao",
      "doi-asserted-by": "publisher",
      "first-page": "3107",
      "journal-title": "Oncogene",
      "key": "592_CR71",
      "unstructured": "Zhao D, Pan C, Sun J, Gilbert C, Drews-Elger K, Azzam DJ, et al. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2. Oncogene. 2015;34:3107–19.",
      "volume": "34",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nrc3818",
      "author": "H Yu",
      "doi-asserted-by": "publisher",
      "first-page": "736",
      "journal-title": "Nat Rev Cancer",
      "key": "592_CR72",
      "unstructured": "Yu H, Lee H, Herrmann A, Buettner R, Jove R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer. 2014;14:736–46.",
      "volume": "14",
      "year": "2014"
    },
    {
      "DOI": "10.1056/NEJMra0804615",
      "author": "JHJ Hoeijmakers",
      "doi-asserted-by": "publisher",
      "first-page": "1475",
      "journal-title": "N Engl J Med",
      "key": "592_CR73",
      "unstructured": "Hoeijmakers JHJ. DNA damage, aging, and Cancer. N Engl J Med. 2009;361:1475–85.",
      "volume": "361",
      "year": "2009"
    },
    {
      "DOI": "10.1093/nar/gkv1160",
      "author": "CA Sloan",
      "doi-asserted-by": "publisher",
      "first-page": "D726",
      "journal-title": "Nucleic Acids Res",
      "key": "592_CR74",
      "unstructured": "Sloan CA, Chan ET, Davidson JM, Malladi VS, Strattan JS, Hitz BC, et al. ENCODE data at the ENCODE portal. Nucleic Acids Res. 2016;44:D726–32.",
      "volume": "44",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.molonc.2012.09.005",
      "author": "SS Nair",
      "doi-asserted-by": "publisher",
      "first-page": "611",
      "journal-title": "Mol Oncol",
      "key": "592_CR75",
      "unstructured": "Nair SS, Kumar R. Chromatin remodeling in cancer: a gateway to regulate gene transcription. Mol Oncol. 2012;6:611–9.",
      "volume": "6",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s11010-012-1302-2",
      "author": "X Shi",
      "doi-asserted-by": "publisher",
      "first-page": "251",
      "journal-title": "Mol Cell Biochem",
      "key": "592_CR76",
      "unstructured": "Shi X, Garry DJ. Sin3 interacts with Foxk1 and regulates myogenic progenitors. Mol Cell Biochem. 2012;366:251–8.",
      "volume": "366",
      "year": "2012"
    },
    {
      "DOI": "10.1038/sj.onc.1209080",
      "author": "S Gordon",
      "doi-asserted-by": "publisher",
      "first-page": "1125",
      "journal-title": "Oncogene",
      "key": "592_CR77",
      "unstructured": "Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene. 2006;25:1125–42.",
      "volume": "25",
      "year": "2006"
    },
    {
      "DOI": "10.1371/journal.pone.0050183",
      "author": "P-H Sun",
      "doi-asserted-by": "publisher",
      "first-page": "e50183",
      "journal-title": "PLoS ONE",
      "key": "592_CR78",
      "unstructured": "Sun P-H, Ye L, Mason MD, Jiang WG. Protein tyrosine phosphatase µ (PTP µ or PTPRM), a negative Regulator of Proliferation and Invasion of breast Cancer cells, is Associated with Disease Prognosis. PLoS ONE. 2012;7:e50183.",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1038/srep09633",
      "doi-asserted-by": "crossref",
      "key": "592_CR79",
      "unstructured": "Sudhir P-R, Lin S-T, Chia-Wen C, Yang S-H, Li AF-Y, Lai R-H et al. Loss of PTPRM Associates with the Pathogenic Development of Colorectal Adenoma-Carcinoma Sequence. Sci Reports 2015 51. 2015;5:1–9."
    },
    {
      "author": "ST Shu",
      "first-page": "1937",
      "journal-title": "Anticancer Res",
      "key": "592_CR80",
      "unstructured": "Shu ST, Sugimoto Y, Liu S, Chang H-L, Ye W, Wang L-S, et al. Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells. Anticancer Res. 2010;30:1937–46.",
      "volume": "30",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.bbcan.2021.188562",
      "author": "P-P Gao",
      "doi-asserted-by": "publisher",
      "first-page": "188562",
      "journal-title": "Biochim Biophys Acta - Rev Cancer",
      "key": "592_CR81",
      "unstructured": "Gao P-P, Qi X-W, Sun N, Sun Y-Y, Zhang Y, Tan X-N, et al. The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer. Biochim Biophys Acta - Rev Cancer. 2021;1876:188562.",
      "volume": "1876",
      "year": "2021"
    },
    {
      "DOI": "10.1038/ng.2653",
      "author": "J Lonsdale",
      "doi-asserted-by": "publisher",
      "first-page": "580",
      "journal-title": "Nat Genet",
      "key": "592_CR82",
      "unstructured": "Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, et al. Nat Genet. 2013;45:580–5. The Genotype-Tissue Expression (GTEx) project.",
      "volume": "45",
      "year": "2013"
    },
    {
      "DOI": "10.1021/acscentsci.9b00909",
      "author": "M Köhn",
      "doi-asserted-by": "publisher",
      "first-page": "467",
      "journal-title": "ACS Cent Sci",
      "key": "592_CR83",
      "unstructured": "Köhn M. Turn and face the strange: a New View on Phosphatases. ACS Cent Sci. 2020;6:467–77.",
      "volume": "6",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41389-019-0187-2",
      "author": "J-Y Im",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Oncogenesis",
      "key": "592_CR84",
      "unstructured": "Im J-Y, Kim B-K, Lee K-W, Chun S-Y, Kang M-J, Won M. DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells. Oncogenesis. 2020;9:1.",
      "volume": "9",
      "year": "2020"
    },
    {
      "DOI": "10.1158/1535-7163.MCT-10-0416",
      "author": "J Yang",
      "doi-asserted-by": "publisher",
      "first-page": "3386",
      "journal-title": "Mol Cancer Ther",
      "key": "592_CR85",
      "unstructured": "Yang J, Ikezoe T, Nishioka C, Furihata M, Yokoyama A. AZ960, a novel Jak2 inhibitor, induces growth arrest and apoptosis in adult T-cell leukemia cells. Mol Cancer Ther. 2010;9:3386–95.",
      "volume": "9",
      "year": "2010"
    },
    {
      "DOI": "10.3390/ijms222111659",
      "doi-asserted-by": "crossref",
      "key": "592_CR86",
      "unstructured": "Mongre RK, Mishra CB, Shukla AK, Prakash A, Jung S, Ashraf-Uz-zaman M et al. Emerging importance of tyrosine kinase inhibitors against Cancer: Quo Vadis to cure? Int J Mol Sci. 2021;22."
    },
    {
      "DOI": "10.18632/oncotarget.24368",
      "author": "ES Han",
      "doi-asserted-by": "publisher",
      "first-page": "24304",
      "journal-title": "Oncotarget",
      "key": "592_CR87",
      "unstructured": "Han ES, Wen W, Dellinger TH, Wu J, Lu SA, Jove R, et al. Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer. Oncotarget. 2018;9:24304.",
      "volume": "9",
      "year": "2018"
    },
    {
      "DOI": "10.1042/BJ20091413",
      "author": "J Omerovic",
      "doi-asserted-by": "publisher",
      "first-page": "65",
      "journal-title": "Biochem J",
      "key": "592_CR88",
      "unstructured": "Omerovic J, Clague MJ, Prior IA. Phosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in ras-mutated cancer cells. Biochem J. 2010;426:65–72.",
      "volume": "426",
      "year": "2010"
    },
    {
      "key": "592_CR89",
      "unstructured": "Wu C-W, Chen J-H, Kao H-L, Li AFY, Lai C-H, Chi C-W et al. PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma. Anticancer Res 26:1643–9."
    },
    {
      "DOI": "10.1101/gr.156539.113",
      "author": "B Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "1522",
      "journal-title": "Genome Res",
      "key": "592_CR90",
      "unstructured": "Zhang B, Zhou Y, Lin N, Lowdon RF, Hong C, Nagarajan RP, et al. Functional DNA methylation differences between tissues, cell types, and across individuals discovered using the M\u0026M algorithm. Genome Res. 2013;23:1522–40.",
      "volume": "23",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nature05610",
      "author": "C Greenman",
      "doi-asserted-by": "publisher",
      "first-page": "153",
      "journal-title": "Nature",
      "key": "592_CR91",
      "unstructured": "Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007;446:153–8.",
      "volume": "446",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.tips.2017.03.004",
      "author": "SM Stanford",
      "doi-asserted-by": "publisher",
      "first-page": "524",
      "journal-title": "Trends Pharmacol Sci",
      "key": "592_CR92",
      "unstructured": "Stanford SM, Bottini N. Targeting tyrosine phosphatases: time to end the Stigma. Trends Pharmacol Sci. 2017;38:524–40.",
      "volume": "38",
      "year": "2017"
    },
    {
      "DOI": "10.1038/onc.2015.171",
      "author": "ND Peyser",
      "doi-asserted-by": "publisher",
      "first-page": "1163",
      "journal-title": "Oncogene",
      "key": "592_CR93",
      "unstructured": "Peyser ND, Freilino M, Wang L, Zeng Y, Li H, Johnson DE, et al. Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer. Oncogene. 2016;35:1163–9.",
      "volume": "35",
      "year": "2016"
    },
    {
      "DOI": "10.3390/cancers10090314",
      "author": "H-C Hsu",
      "doi-asserted-by": "publisher",
      "first-page": "314",
      "journal-title": "Cancers (Basel)",
      "key": "592_CR94",
      "unstructured": "Hsu H-C, Lapke N, Chen S-J, Lu Y-J, Jhou R-S, Yeh C-Y, et al. PTPRT and PTPRD deleterious mutations and deletion predict Bevacizumab Resistance in Metastatic Colorectal Cancer patients. Cancers (Basel). 2018;10:314.",
      "volume": "10",
      "year": "2018"
    },
    {
      "DOI": "10.1038/nrc2734",
      "author": "H Yu",
      "doi-asserted-by": "publisher",
      "first-page": "798",
      "journal-title": "Nat Rev Cancer",
      "key": "592_CR95",
      "unstructured": "Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9:798–809.",
      "volume": "9",
      "year": "2009"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-09-4368",
      "author": "M Glondu-Lassis",
      "doi-asserted-by": "publisher",
      "first-page": "5116",
      "journal-title": "Cancer Res",
      "key": "592_CR96",
      "unstructured": "Glondu-Lassis M, Dromard M, Lacroix-Triki M, Nirdé P, Puech C, Knani D, et al. PTPL1/PTPN13 regulates breast Cancer Cell aggressiveness through direct inactivation of Src Kinase. Cancer Res. 2010;70:5116–26.",
      "volume": "70",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.bbrc.2005.12.164",
      "author": "MD Planas-Silva",
      "doi-asserted-by": "publisher",
      "first-page": "73",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "592_CR97",
      "unstructured": "Planas-Silva MD, Bruggeman RD, Grenko RT, Stanley Smith J. Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer. Biochem Biophys Res Commun. 2006;341:73–81.",
      "volume": "341",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nm.2795",
      "author": "JM Balko",
      "doi-asserted-by": "publisher",
      "first-page": "1052",
      "journal-title": "Nat Med",
      "key": "592_CR98",
      "unstructured": "Balko JM, Cook RS, Vaught DB, Kuba MG, Miller TW, Bhola NE, et al. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance. Nat Med. 2012;18:1052–9.",
      "volume": "18",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.bbrc.2014.11.011",
      "author": "T Yang",
      "doi-asserted-by": "publisher",
      "first-page": "298",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "592_CR99",
      "unstructured": "Yang T, Li X-N, Li X-G, Li M, Gao P-Z. DNAJC6 promotes hepatocellular carcinoma progression through induction of epithelial–mesenchymal transition. Biochem Biophys Res Commun. 2014;455:298–304.",
      "volume": "455",
      "year": "2014"
    },
    {
      "DOI": "10.1038/s41576-018-0074-2",
      "author": "M Berdasco",
      "doi-asserted-by": "publisher",
      "first-page": "109",
      "journal-title": "Nat Rev Genet",
      "key": "592_CR100",
      "unstructured": "Berdasco M, Esteller M. Clinical epigenetics: seizing opportunities for translation. Nat Rev Genet. 2019;20:109–27.",
      "volume": "20",
      "year": "2019"
    }
  ],
  "reference-count": 100,
  "references-count": 100,
  "relation": {
    "has-preprint": [
      {
        "asserted-by": "object",
        "id": "10.21203/rs.3.rs-3550589/v1",
        "id-type": "doi"
      }
    ]
  },
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-024-00592-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Cellular and clinical impact of protein phosphatase enzyme epigenetic silencing in multiple cancer tissues"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "18"
}